Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections

0531787 - ÚIACH 2021 RIV CH eng J - Článek v odborném periodiku
Vacek, L. - Kobzová, Š. - Čmelík, Richard - Pantůček, R. - Janda, L.
Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections.
Antibiotics (Basel). Roč. 9, č. 8 (2020), č. článku 519. ISSN 2079-6382. E-ISSN 2079-6382
Institucionální podpora: RVO:68081715
Klíčová slova: enzyme therapy * enzybiotics * lysostaphin
Obor OECD: Analytical chemistry
Impakt faktor: 4.639, rok: 2020
Způsob publikování: Omezený přístup

Antistaphylococcal enzymes derived from lysostaphin and endolysin were modified in order to improve their antimicrobial properties and stability. These antimicrobial enzymes proved to be efficient in killing of the diverse strains of methicillin-resistant Staphylococcus aureus.
Trvalý link: http://hdl.handle.net/11104/0310404